Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Liver Diseases

  Free Subscription

Articles published in Gastroenterology

Retrieve available abstracts of 320 articles:
HTML format

Single Articles

    May 2020
  1. DING X, He M, Chan AWH, Song QX, et al
    Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30659.
    PubMed     Abstract available

  2. HAJIFATHALIAN K, Krisko T, Mehta A, Kumar S, et al
    Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30602.

  3. KIM D, Konyn P, Cholankeril G, Wong RJ, et al
    Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30599.

  4. MAHMUD N, Hubbard RA, Kaplan DE, Serper M, et al
    Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study.
    Gastroenterology. 2020 May 5. pii: S0016-5085(20)30597.

    April 2020
  5. NOUREDDIN M, Chan JL, Barradas K, Dimick-Santos L, et al
    Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum.
    Gastroenterology. 2020 Apr 27. pii: S0016-5085(20)30556.

  6. PONTES AFECTO EM, Joao DA, Resende Rodrigues MA
    Unusual esophageal polyps in advanced cirrhosis.
    Gastroenterology. 2020 Apr 23. pii: S0016-5085(20)30559.

  7. GOTFRIED J, Naftali T, Schey R
    Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gastroenterology. 2020 Apr 22. pii: S0016-5085(20)30563.
    PubMed     Abstract available

  8. KRIETMAN K, Snell PD, Kothadia JP
    An Uncommon Cause of Hepatic Hematoma.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30508.

  9. CARVAO J, Pereira VM, Jasmins L
    A case of unexplained cutaneous lesions, cholestatic hepatitis and non-cirrhotic portal hypertension in a female patient.
    Gastroenterology. 2020 Apr 16. pii: S0016-5085(20)30494.

  10. KAMBOJ AK, Yung-Lun Chin J, Huebert RC
    A Curious Case of Confusion in a Patient with Cirrhosis.
    Gastroenterology. 2020 Apr 15. pii: S0016-5085(20)30513.

  11. KUNG-CHUN CHIU D, Wai-Hin Yuen V, Wing-Sum Cheu J, Wei LL, et al
    Hepatocellular Carcinoma Cells Upregulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Gastroenterology. 2020 Apr 7. pii: S0016-5085(20)30461.
    PubMed     Abstract available

    March 2020
  12. EL-SERAG HB, Kanwal F, Feng Z, Marrero JA, et al
    Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings from Texas Hepatocellular Carcinoma Consortium Cohort.
    Gastroenterology. 2020 Mar 29. pii: S0016-5085(20)30403.

  13. KAMAL F, Khan MA
    Is tenofovir associated with lower risk of hepatocellular carcinoma in patients with chronic hepatitis B compared to entecavir?
    Gastroenterology. 2020 Mar 19. pii: S0016-5085(20)30373.

  14. LEE HA, Seo YS, Kim SU
    Risk of Hepatocellular Carcinoma with Tenofovir vs. Entecavir in Patients with Chronic Hepatitis B.
    Gastroenterology. 2020 Mar 19. pii: S0016-5085(20)30374.

  15. WANG F, Hou W, Chitsike L, Xu Y, et al
    ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Gastroenterology. 2020 Mar 11. pii: S0016-5085(20)30334.
    PubMed     Abstract available

  16. MEJIAS M, Gallego J, Naranjo-Suarez S, Ramirez M, et al
    CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30328.
    PubMed     Abstract available

    Can macrophages in cirrhotic ascites fluid predict clinical outcome in SBP?
    Gastroenterology. 2020 Mar 2. pii: S0016-5085(20)30267.

  18. LIU P, Liang B, Liu M, Lebbink JHG, et al
    Oncogenic Mutations in Armadillo Repeats 5 and 6 of beta-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes.
    Gastroenterology. 2020;158:1029-1043.
    PubMed     Abstract available

    February 2020
  19. HOWELL DJ, Chan HL, Feld JJ, Hellard ME, et al
    Closing the stable door after the horse has bolted - should we be treating people with immune-tolerant chronic hepatitis B to prevent hepatocellular carcinoma?
    Gastroenterology. 2020 Feb 20. pii: S0016-5085(20)30238.

  20. GEHRKE N, Schattenberg JM
    Metabolic inflammation - a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30230.
    PubMed     Abstract available

  21. LI D, Li N, Zhang YF, Fu H, et al
    Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.
    Gastroenterology. 2020 Feb 11. pii: S0016-5085(20)30211.
    PubMed     Abstract available

  22. ESHKENAZY R, Inbal Y, Azoulay D
    A New Cause of Cholangitis Following Roux-en-Y Hepaticojejunostomy.
    Gastroenterology. 2020 Feb 1. pii: S0016-5085(20)30130.

  23. BIECHELE J, Fox M
    A Patient with Metastatic Lung Cancer and Dysphagia.
    Gastroenterology. 2020;158:485-487.

    January 2020
  24. LOOMBA R, Lim JK, Patton H, El-Serag HB, et al
    AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2020 Jan 29. pii: S0016-5085(20)30127.
    PubMed     Abstract available

  25. STENGEL S, Quickert S, Lutz P, Ibidapo-Obe O, et al
    Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis.
    Gastroenterology. 2020 Jan 23. pii: S0016-5085(20)30121.
    PubMed     Abstract available

  26. LIN YH, Zhang S, Zhu M, Lu T, et al
    Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity but Develop Fewer Tumors Following Chronic Liver Injury.
    Gastroenterology. 2020 Jan 20. pii: S0016-5085(20)30116.
    PubMed     Abstract available

  27. LIU X, Xu J, Rosenthal S, Zhang LJ, et al
    Identification of Lineage-specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
    Gastroenterology. 2020 Jan 20. pii: S0016-5085(20)30117.
    PubMed     Abstract available

  28. SHIELS MS, O'Brien TR
    Recent Decline in Hepatocellular Carcinoma Rates in the United States.
    Gastroenterology. 2020 Jan 18. pii: S0016-5085(20)30010.

  29. LO GH
    Did direct-acting antiviral therapy for hepatitis C virus infection really improve the survival of patients with hepatocellular carcinoma ?
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30102.

  30. YOUNOSSI ZM, Henry L
    Are Noninvasive Scoring Systems for Persons With Chronic Liver Disease Ready for Prime Time?
    Gastroenterology. 2020;158:40-42.

  31. VERHELST X, Dias AM, Colombel JF, Vermeire S, et al
    Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases.
    Gastroenterology. 2020;158:95-110.
    PubMed     Abstract available

  32. HAGSTROM H, Talback M, Andreasson A, Walldius G, et al
    Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.
    Gastroenterology. 2020;158:200-214.
    PubMed     Abstract available

  33. QUACH B, Han S, Attwell A
    Septic Shock After Travel to Rural Africa.
    Gastroenterology. 2020;158:56-57.

  34. YANAI M, Yamamoto A, Itou S
    Multiple Low-Density Areas in the Liver.
    Gastroenterology. 2020;158:e7-e8.

  35. DONG ZR, Zhi XT, Li T
    A Rapidly Progressing Polycystic Liver Disease?
    Gastroenterology. 2020;158:e9-e11.

    December 2019
  36. CHALASANI N, Abdelmalek MF, Garcia-Tsao G, Vuppalanchi R, et al
    Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension.
    Gastroenterology. 2019 Dec 5. pii: S0016-5085(19)41895.
    PubMed     Abstract available

  37. LIU T, Shyh-Chang N
    Oncofetal SALL4-Driven Tumorigenesis Is Highly Dependent on Oxidative Phosphorylation, Revealing Therapeutic Opportunities.
    Gastroenterology. 2019;157:1475-1477.

  38. GURM H, Jamorabo DS, Mohanty SR
    Weight Loss and Granulomatous Liver Disease.
    Gastroenterology. 2019;157:e3-e5.

  39. VOS MB, Dimick-Santos L, Mehta R, Omokaro SO, et al
    Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;157:1448-1456.

  40. TAN JL, Li F, Yeo JZ, Yong KJ, et al
    New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
    Gastroenterology. 2019;157:1615-1629.
    PubMed     Abstract available

    November 2019
  41. LAMPERTICO P, Papatheodoridis GV
    Gastroenterology. 2019 Nov 7. pii: S0016-5085(19)41524.

  42. SHEN T, Mao Y, Chen C
    Gastroenterology. 2019;157:1439-1440.

  43. DEVARBHAVI H, Bjornsson ES
    RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Gastroenterology. 2019;157:1437-1438.

  44. CONG W, Xin Q, Gao Y
    RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Gastroenterology. 2019;157:1438-1439.

  45. YANG M, Li Z, Dou D
    Can Retrospective Studies Confirm Causes of Drug-Induced Liver Injury?
    Gastroenterology. 2019;157:1436-1437.

  46. BAJAJ JS, Sharma A, Dudeja PK
    Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans.
    Gastroenterology. 2019;157:1180-1183.

  47. GHABRIL M, Gu J, Yoder L, Corbito L, et al
    Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.
    Gastroenterology. 2019;157:1245-1252.
    PubMed     Abstract available

    October 2019
  48. XIANG J, Zhang N, Sun H, Su L, et al
    Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of PD-L1 in Hepatocellular Carcinoma Cells.
    Gastroenterology. 2019 Oct 30. pii: S0016-5085(19)41477.
    PubMed     Abstract available

  49. CARUSO S, Nault JC
    A dive into the deep heterogeneity of hepatocellular carcinoma.
    Gastroenterology. 2019 Oct 10. pii: S0016-5085(19)41420.

  50. LE BERRE C, Sandborn WJ, Aridhi S, Devignes MD, et al
    Application of Artificial Intelligence to Gastroenterology and Hepatology.
    Gastroenterology. 2019 Oct 5. pii: S0016-5085(19)41412.
    PubMed     Abstract available

  51. SUNDARAM V, Jalan R
    Gastroenterology. 2019;157:1163-1164.

  52. WRIGHT GEB, Drogemoller BI, Ross CJD, Carleton BC, et al
    Genome-Wide Association Studies of Drug-Induced Liver Injury Make Progress Beyond the HLA Region.
    Gastroenterology. 2019;157:1167-1168.

  53. CHOUDHARY NS, Saraf N, Saigal S, Soin AS, et al
    Factors Associated With Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: Unanswered Questions.
    Gastroenterology. 2019;157:1162-1163.

    September 2019
  54. CHEUK-FUNG YIP T, Wai-Sun Wong V, Lik-Yuen Chan H, Tse YK, et al
    Tenofovir is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.
    Gastroenterology. 2019 Sep 28. pii: S0016-5085(19)41367.
    PubMed     Abstract available

  55. TRIPATHI A, Paspulati R, Cohen SM
    Dyspnea in Hepatocellular Carcinoma.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41355.

  56. DING X, He M, Chan AWH, Song QX, et al
    Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41338.
    PubMed     Abstract available

    Gastroenterology. 2019;157:901-902.

  58. BAJAJ JS, Gillevet PM
    Gastroenterology. 2019;157:902-903.

    Historical Data Are Not Relevant to the Diagnostic Performance of Ultrasound in Surveillance for Hepatocellular Carcinoma.
    Gastroenterology. 2019;157:899-900.

  60. NAYAK LJ, Sondhi AR, Westerhoff M
    A Rare Complication of a Rare Disease.
    Gastroenterology. 2019;157:616-618.

  61. ESLAM M, Sanyal AJ, George J
    Toward More Accurate Nomenclature for Fatty Liver Diseases.
    Gastroenterology. 2019;157:590-593.

  62. HAMESCH K, Mandorfer M, Pereira VM, Moeller LS, et al
    Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
    Gastroenterology. 2019;157:705-719.
    PubMed     Abstract available

    August 2019
  63. TSENG TC, Liu CJ, Hsu CY, Hong CM, et al
    High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41248.
    PubMed     Abstract available

  64. TAO H, Chen X
    The role of CXCR6 deficient Natural Killer T- and CD4 + T cells in hepatocarcinogenesis.
    Gastroenterology. 2019 Aug 7. pii: S0016-5085(19)41194.

  65. TEMMERMAN F, Nevens F
    Further Evidence That Lanreotide Reduces Liver Growth in Patients With Polycystic Liver Disease, But Not the End of the Story.
    Gastroenterology. 2019;157:298-299.

  66. TORRES S, Baulies A, Insausti-Urkia N, Alarcon-Vila C, et al
    Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver Failure.
    Gastroenterology. 2019;157:552-568.
    PubMed     Abstract available

  67. VAN AERTS RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, et al
    Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
    Gastroenterology. 2019;157:481-491.
    PubMed     Abstract available

  68. XIAO X, Chen L, Wu H
    Liver Masses.
    Gastroenterology. 2019;157:e3-e4.

  69. ZHUANG BW, Wang W, Xie XY
    A Rare Case of Liver Tumor.
    Gastroenterology. 2019;157:e5-e7.

  70. SHAH-KHAN SM, Hsueh W, Reynolds GJ
    An 8-Year History of Increased Level of Aspartate Aminotransferase.
    Gastroenterology. 2019;157:318-319.

    July 2019
  71. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma.
    Gastroenterology. 2019 Jul 30. pii: S0016-5085(19)41137.
    PubMed     Abstract available

  72. FAN W, Liu T, Chen W, Hammad S, et al
    ECM1 Prevents Activation of Transforming Growth Factor beta, Hepatic Stellate Cells, and Fibrogenesis in Mice.
    Gastroenterology. 2019 Jul 27. pii: S0016-5085(19)41133.
    PubMed     Abstract available

  73. IOANNOU GN, Beste LA, Green PK, Singal AG, et al
    Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores.
    Gastroenterology. 2019 Jul 26. pii: S0016-5085(19)41130.
    PubMed     Abstract available

  74. MORAN-SALVADOR E, Garcia-Macia M, Sivaharan A, Sabater L, et al
    Fibrogenic Activity of MECP2 is Regulated by Phosphorylation in Hepatic Stellate Cells.
    Gastroenterology. 2019 Jul 25. pii: S0016-5085(19)41126.
    PubMed     Abstract available

  75. MOEINI A, Torrecilla S, Tovar V, Montironi C, et al
    An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Gastroenterology. 2019 Jul 22. pii: S0016-5085(19)41121.
    PubMed     Abstract available

  76. PANEL M, Isaac Ruiz, Rozenn Brillet, Lafdil F, et al
    Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia-reperfusion injury.
    Gastroenterology. 2019 Jul 20. pii: S0016-5085(19)41119.
    PubMed     Abstract available

  77. LO GH
    The transplantation of fecal microbiota for cirrhotic patients.
    Gastroenterology. 2019 Jul 12. pii: S0016-5085(19)41090.

  78. JAIN A, Scavo L, Cross D, Petney M, et al
    PeriLeve: An Implantable Peritoneovesicular Biopowered Shunt to Manage Patients with Refractory Ascites.
    Gastroenterology. 2019;157:21-22.

    June 2019
  79. SCHWIMMER JB, Johnson JS, Angeles JE, Behling C, et al
    Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019 Jun 27. pii: S0016-5085(19)41037.
    PubMed     Abstract available

  80. GOUGELET A, Sartor C, Senni N, Calderaro J, et al
    Hepatocellular Carcinomas With Mutational Activation of Beta Catenin Require Choline and can be Detected by Positron Emission Tomography.
    Gastroenterology. 2019 Jun 10. pii: S0016-5085(19)40988.
    PubMed     Abstract available

  81. YAN J, Tung HC, Li S, Niu Y, et al
    Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
    Gastroenterology. 2019 Jun 3. pii: S0016-5085(19)40984.
    PubMed     Abstract available

  82. MORO A, Okubo K, Sasaki K
    Goodbye for Good: Stepping Away From Recurrence.
    Gastroenterology. 2019;156:2353-2354.

  83. SHEN T, Liu Y, Shang J, Xie Q, et al
    Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Gastroenterology. 2019;156:2230-2241.
    PubMed     Abstract available

  84. HSU YC, Huang WH
    Abdominal Semicircular Calcified Lesion in a Febrile Woman.
    Gastroenterology. 2019;156:e7-e8.

    May 2019
  85. WIDJAJA AA, Singh BK, Adami E, Viswanathan S, et al
    Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Non-Alcoholic Steatohepatitis.
    Gastroenterology. 2019 May 8. pii: S0016-5085(19)40858.
    PubMed     Abstract available

  86. CARUSO S, Calatayud AL, Pilet J, La Bella T, et al
    Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
    Gastroenterology. 2019 May 4. pii: S0016-5085(19)36771.
    PubMed     Abstract available

  87. AGRAWAL R, Majeed M, Gandhi S
    An unusual cause of esophageal varices.
    Gastroenterology. 2019 May 4. pii: S0016-5085(19)36770.

  88. BHAN I, Aryee M, Ting DT
    Gastroenterology. 2019;156:1933-1934.

  89. WANG J, Dong R, Zheng S
    Circulating Epithelial Cells in Patients With Liver Disease.
    Gastroenterology. 2019;156:1932.

  90. ROOS FJM, IJzermans JNM, van der Laan LJW
    Reply to "Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies from Patients with Liver Disease": Implications for Transplant Chimerism.
    Gastroenterology. 2019;156:1932-1933.

  91. HADDAD FG, Mulrooney S
    A Shiny Liver!
    Gastroenterology. 2019;156:1580-1581.

  92. LI H, Li CW, Li X, Ding Q, et al
    MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.
    Gastroenterology. 2019;156:1849-1861.
    PubMed     Abstract available

  93. EDDOWES PJ, Sasso M, Allison M, Tsochatzis E, et al
    Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1717-1730.
    PubMed     Abstract available

  94. CIRULLI ET, Nicoletti P, Abramson K, Andrade RJ, et al
    A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.
    Gastroenterology. 2019;156:1707-1716.
    PubMed     Abstract available

    April 2019
  95. KIM HP, Moon AM, Dellon ES
    Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients with Varices: You Have Some Ex-Spleening to Do.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36721.

  96. LOHMANN V, Bartenschlager R
    Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36726.

  97. KIM SB, Kim JW, Choi JH
    A rare cause of multiple hepatic masses.
    Gastroenterology. 2019 Apr 14. pii: S0016-5085(19)35696.

  98. O'LEARY JG, Greenberg CS, Patton HM, Caldwell SH, et al
    Coagulation in Cirrhosis.
    Gastroenterology. 2019 Apr 12. pii: S0016-5085(19)35694.

  99. CASTERA L, Friedrich-Rust M, Loomba R
    Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1264-1281.
    PubMed     Abstract available

  100. CAI M, Kabir T, Jeyaraj PR
    A Curious Case of Refractory Hematochezia.
    Gastroenterology. 2019;156:e12-e13.

  101. SUNDARAM V, Jalan R, Wu T, Volk ML, et al
    Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Gastroenterology. 2019;156:1381-1391.
    PubMed     Abstract available

    March 2019
  102. FRANSES JW, Zhu AX
    Has PD-1 MET its match in hepatocellular carcinoma?
    Gastroenterology. 2019 Mar 26. pii: S0016-5085(19)34585.

  103. NAULT JC, Nahon P
    Direct Antiviral Agents and the Risk of Recurrence of Hepatocellular Carcinoma: Moving on?
    Gastroenterology. 2019 Mar 26. pii: S0016-5085(19)34583.

  104. FERNANDEZ J, Claria J, Amoros A, Aguilar F, et al
    Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
    Gastroenterology. 2019 Mar 21. pii: S0016-5085(19)33576.
    PubMed     Abstract available

  105. LOMBARDI A, Mondelli MU, Bruno R
    RE: Effects of long-term norfloxacin therapy in patients with advanced cirrhosis.
    Gastroenterology. 2019 Mar 14. pii: S0016-5085(19)33560.

  106. RAYAR M, Bardou-Jacquet E
    Recurrence of primary biliary cholangitis after liver transplantation: Is Tacrolimus really worse than other drugs?
    Gastroenterology. 2019 Mar 14. pii: S0016-5085(19)33562.

  107. SINGAL AG, Lim JK, Kanwal F
    AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2019 Mar 13. pii: S0016-5085(19)33558.

  108. HILSCHER MB, Sehrawat T, Arab Verdugo JP, Zeng Z, et al
    Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension.
    Gastroenterology. 2019 Mar 11. pii: S0016-5085(19)33554.
    PubMed     Abstract available

  109. ARROYO V
    Acute-On-Chronic Liver Failure in Cirrhosis Requires Expedited Decision for Liver Transplantation.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32514.

  110. MARQUARDT P, Hoshida Y, Singal AG
    Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32516.

  111. MOON AM, Weiss NS, Beste LA, Su F, et al
    Gastroenterology. 2019;156:1218-1220.

  112. VALOBRA T, Ceratti U, Gandino A
    Abdominal Septic Shock: An Eye-Popping Case.
    Gastroenterology. 2019;156:881-882.

    February 2019
  113. CHEN CY, Wang YP, Lu CL
    An Unusual Hepatic Mass in a Young Man.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32489.

  114. RAVINDRANATH A, Sarma MS, Yachha SK
    An elusive diagnosis in a child with fever and hepatomegaly.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32492.

  115. BRUIX J, Ayuso C
    Diagnosis of Hepatic Nodules in Patients at Risk for Hepatocellular Carcinoma: LI-RADS Probability Versus Certainty.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30381.

    The Changing Scenario of Screening and Surveillance of Esophageal Varices.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30384.

  117. INTAGLIATA NM, Caldwell SH, Tripodi A
    Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
    Gastroenterology. 2019 Feb 13. pii: S0016-5085(19)30372.
    PubMed     Abstract available

  118. THABUT D, Bureau C, Layese R, Bourcier V, et al
    Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(18)35303.
    PubMed     Abstract available

  119. TEUFEL M, Seidel H, Kochert K, Meinhardt G, et al
    Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma.
    Gastroenterology. 2019 Feb 6. pii: S0016-5085(19)30361.
    PubMed     Abstract available

    What Did We Learn From the ADAPT Trials?
    Gastroenterology. 2019;156:824-825.

    January 2019
  121. TAN AT, Yang N, Krishnamoorthy TL, Oei V, et al
    Use of Expression Profiles of HBV DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
    Gastroenterology. 2019 Jan 31. pii: S0016-5085(19)30348.
    PubMed     Abstract available

  122. WEI Y, Lao XM, Xiao X, Wang XY, et al
    Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Gastroenterology. 2019 Jan 31. pii: S0016-5085(19)30347.
    PubMed     Abstract available

  123. MOSSANEN JC, Kohlhepp M, Wehr A, Krenkel O, et al
    CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T and CD4+ T cell-Dependent Control of Senescence.
    Gastroenterology. 2019 Jan 30. pii: S0016-5085(19)30342.
    PubMed     Abstract available

  124. GRINDHEIM JM, Nicetto D, Donahue G, Zaret KS, et al
    PRC2 proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Gene Expression at Promoter Regions in Euchromatin in Mice.
    Gastroenterology. 2019 Jan 25. pii: S0016-5085(19)30104.
    PubMed     Abstract available

  125. BAJAJ JS, Fagan A, Gavis EA, Kassam Z, et al
    Long-term Outcomes after Fecal Microbiota Transplant in Cirrhosis.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30093.

  126. MULLANY K, Arbuckle S, Mei-Ling Siew S
    A Rare Cause of Neonatal Cholestasis without Liver Dysfunction.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30091.

  127. LAI JC, Rahimi R, Verna EC, Kappus MR, et al
    Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30058.
    PubMed     Abstract available

  128. KAPLAN DE, Serper M, Mehta R, Fox R, et al
    Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30053.
    PubMed     Abstract available

  129. SINGAL AG, Rich NE, Mehta N, Branch A, et al
    Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
    Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30057.
    PubMed     Abstract available

  130. CHATURANTABUT S, Shwartz A, Evason KJ, Cox AG, et al
    Estrogen Activation of G protein-coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.
    Gastroenterology. 2019 Jan 11. pii: S0016-5085(19)30031.
    PubMed     Abstract available

  131. KO S, Russell JO, Tian J, Gao C, et al
    Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.
    Gastroenterology. 2019;156:187-202.
    PubMed     Abstract available

    December 2018
  132. LIANG TJ, Terrault N
    Viral Hepatitis and Hepatocellular Carcinoma.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35423.

  133. PIANO S, Singh V, Caraceni P, Maiwall R, et al
    Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Gastroenterology. 2018 Dec 12. pii: S0016-5085(18)35402.
    PubMed     Abstract available

  134. SINGAL AG, Murphy CC
    Hepatocellular Carcinoma Surveillance: An effective but complex process.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35393.

  135. MAJEED A, Roberts SK, Kemp W
    RE: No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35391.

  136. MEHTA N, Monto A, Yao FY
    Screening for hepatocellular carcinoma to improve cancer-related mortality: Looking behind when we should be looking ahead.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35392.

    Screening For Hepatocellular Carcinoma In Cirrhosis: Challenges And Unresolved Issues.
    Gastroenterology. 2018 Dec 10. pii: S0016-5085(18)35390.

  138. MAHER JJ
    Macrophages Steal STING From the Infectious Disease Playbook to Promote Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:1687-1688.

  139. BHAN I, Mosesso K, Goyal L, Philipp J, et al
    Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease.
    Gastroenterology. 2018;155:2016-2018.

  140. BLACK DD, Gupta SK
    Gastrointestinal Complications and Management of Obesity.
    Gastroenterology. 2018;155:1655-1658.

    November 2018
  141. COSTENTIN CE, Layese R, Roudot-Thoraval F, Audureau E, et al
    Hepatocellular carcinoma screening: seeking a reasonable pathway to move forwards... In reply to "Hepatocellular carcinoma screening: seeking robust evidence" LTE 18-01689.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35294.

  142. SKEF W, Xia Y, Staudacher JJ, Jung B, et al
    Beyond Hospital Rankings: How Do We Measure Academic Strength in Gastroenterology/Hepatology Divisions?
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35289.

  143. POLISHCHUK EV, Merolla A, Lichtmannegger J, Romano A, et al
    Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis.
    Gastroenterology. 2018 Nov 16. pii: S0016-5085(18)35280.
    PubMed     Abstract available

  144. VAN DER POL CB, Lim CS, Sirlin CB, McGrath TA, et al
    Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35262.
    PubMed     Abstract available

  145. LIM U, Monroe KR, Buchthal S, Fan B, et al
    Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35263.
    PubMed     Abstract available

  146. ELSSNER C, Goeppert B, Longerich T, Scherr AL, et al
    Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35260.
    PubMed     Abstract available

  147. SANTOS PM, Butterfield LH
    Next Steps for Immune Checkpoints in Hepatocellular Carcinoma.
    Gastroenterology. 2018 Nov 9. pii: S0016-5085(18)35218.

  148. DHANASEKARAN R, Nault JC, Roberts LR, Zucman-Rossi J, et al
    Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.
    Gastroenterology. 2018 Nov 4. pii: S0016-5085(18)35210.
    PubMed     Abstract available

  149. PRIVITERA G, Figorilli F, Jalan R, Mehta G, et al
    Portosystemic Shunt Embolization and Recurrent Ascites: A Single-Center Case Series.
    Gastroenterology. 2018;155:1649-1650.

    October 2018
  150. KULIK L, El-Serag HB
    Epidemiology and Management of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35165.
    PubMed     Abstract available

    Hepatocellular carcinoma screening: seeking robust evidence ....
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35148.

  152. PEERY AF, Crockett SD, Murphy CC, Lund JL, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35147.
    PubMed     Abstract available

  153. MEHAL WZ
    Acetyl-Coenzyme A carboxylase inhibition in Nonalcoholic Steatohepatitis: Delivering as Anticipated.
    Gastroenterology. 2018 Oct 8. pii: S0016-5085(18)35103.

  154. MONTANO-LOZA AJ, Hansen BE, Corpechot C, Roccarina D, et al
    Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
    Gastroenterology. 2018 Oct 5. pii: S0016-5085(18)35089.
    PubMed     Abstract available

  155. GRETEN TF, Lai CW, Li G, Staveley-O'Carroll KF, et al
    Targeted and Immune-based Therapies for Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35082.
    PubMed     Abstract available

  156. YANG XM, Cao XY, He P, Li J, et al
    Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Gastroenterology. 2018;155:1233-1249.
    PubMed     Abstract available

  157. SIVARAJAH SS, Shahzard S, Chew MH
    Unusual Cause of Liver Abscess.
    Gastroenterology. 2018;155:e7-e8.

    September 2018
  158. ZHAI ZZ, Wang L, Zuo XL
    A Rare Cause of Gastrointestinal Bleeding in a Patient With a History of Alcoholic Cirrhosis.
    Gastroenterology. 2018 Sep 18. pii: S0016-5085(18)35021.

  159. ZHANG XP, Wang K, Cheng SQ
    Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34774.

  160. LOOMBA R, Sanyal AJ, Kowdley KV, Terrault N, et al
    Factors Associated with Histologic Response in Adult Patients with Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34977.
    PubMed     Abstract available

  161. LUO X, Li H, Ma L, Zhou J, et al
    Expression of STING Is Increased in Liver Tissues from Patients With NAFLD and Promotes Macrophage-mediated Hepatic Inflammation and Fibrosis in Mice.
    Gastroenterology. 2018 Sep 10. pii: S0016-5085(18)34959.
    PubMed     Abstract available

  162. COOPER GS
    Should We Abandon Current Hepatocellular Carcinoma Screening Practices?
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34934.

  163. EL-SERAG HB
    Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels.
    Gastroenterology. 2018;155:607-609.

  164. MANSOURI A, Gattolliat CH, Asselah T
    Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.
    Gastroenterology. 2018;155:629-647.
    PubMed     Abstract available

  165. ASRANI SK, Kouznetsova M, Ogola G, Taylor T, et al
    Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013.
    Gastroenterology. 2018;155:719-729.
    PubMed     Abstract available

  166. CHAO X, Wang S, Zhao K, Li Y, et al
    Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice.
    Gastroenterology. 2018;155:865-879.
    PubMed     Abstract available

  167. TERRAULT N, Chen YC, Izumi N, Kayali Z, et al
    Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
    Gastroenterology. 2018;155:705-718.
    PubMed     Abstract available

    August 2018
  168. ROY S, Hooiveld GJ, Seehawer M, Caruso S, et al
    microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-associated Protein 1 to Suppress Hepatocarcinogenesis.
    Gastroenterology. 2018 Aug 27. pii: S0016-5085(18)34918.
    PubMed     Abstract available

  169. KIM HD, Song GW, Park S, Jung MK, et al
    Association Between Expression Level of PD1 by Tumor-Infiltrating CD8(+) T Cells and Features of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Aug 23. pii: S0016-5085(18)34897.
    PubMed     Abstract available

  170. KANWAL F, Kramer JR, Mapakshi S, Natarajan Y, et al
    Risk of Hepatocellular Cancer in Patients with Non-alcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34889.
    PubMed     Abstract available

  171. MOREAU R, Elkrief L, Bureau C, Perarnau JM, et al
    Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34891.
    PubMed     Abstract available

  172. BOYER A, Park SB, de Boer Y, Li Q, et al
    TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34892.
    PubMed     Abstract available

  173. KLEBER G, Sauerbruch T
    Concomitant gastric varices: Bleeding risk sign in patients with liver cirrhosis and esophageal varices?
    Gastroenterology. 2018 Aug 21. pii: S0016-5085(18)34879.

  174. THEVENOT T, Weil D, Di Martino V
    What is the true relationship between spontaneous portosystemic shunts and portopulmonary hypertension in cirrhotic patients?
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34878.

  175. EVERS L, Patel D, Porayko M
    An Unusual Cause of a Liver Mass in a Woman.
    Gastroenterology. 2018;155:e17-e18.

  176. SCHREINER P, Puippe G, Gubler C
    An Unusual, But Potentially Life-Threatening Lesion in the Cecum.
    Gastroenterology. 2018;155:e9-e10.

  177. LOW IW, John Harley HA, Clouston A
    Polycythemia Rubra Vera: Where Does the Truth Lie?
    Gastroenterology. 2018;155:e7-e8.

  178. KAILA V, Lager D, Jain R
    A Rare Tumor Presenting as a Rectal Mass.
    Gastroenterology. 2018;155:273-275.

  179. CHIEN MM, Wu JF, Lin MT
    An Unusual Cause of Cyanosis in a Child.
    Gastroenterology. 2018;155:e5-e6.

  180. VILAR-GOMEZ E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, et al
    Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Gastroenterology. 2018;155:443-457.
    PubMed     Abstract available

  181. AJMERA V, Park CC, Caussy C, Singh S, et al
    Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:307-310.
    PubMed     Abstract available

    July 2018
  182. LOOMBA R, Kayali Z, Noureddin M, Ruane P, et al
    GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients with Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018 Jul 27. pii: S0016-5085(18)34815.
    PubMed     Abstract available

  183. TRIPATHI DM, Vilaseca M, Lafoz E, Garcia-Caldero H, et al
    Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Gastroenterology. 2018 Jul 25. pii: S0016-5085(18)34810.
    PubMed     Abstract available

  184. WILDMAN-TOBRINER B, Middleton MM, Moylan CA, Rossi S, et al
    Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Jul 19. pii: S0016-5085(18)34784.
    PubMed     Abstract available

  185. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    PubMed     Abstract available

  186. HARRISON SA, Abdelmalek MF, Caldwell S, Shiffman ML, et al
    Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Jul 7. pii: S0016-5085(18)34758.
    PubMed     Abstract available

  187. MOON AM, Weiss NS, Beste LA, Su F, et al
    No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Jul 5. pii: S0016-5085(18)34721.
    PubMed     Abstract available

  188. SETHI V, Kurtom S, Tarique M, Lavania S, et al
    Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
    Gastroenterology. 2018;155:33-37.
    PubMed     Abstract available

  189. MA J, Hennein R, Liu C, Long MT, et al
    Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:107-117.
    PubMed     Abstract available

  190. HARRYVAN TJ, Tushuizen ME
    A Young Patient With Diabetes and Liver Tumors.
    Gastroenterology. 2018;155:25-26.

  191. ASHHAB AA, Singh D, Debes JD
    A Rare Cause of a Left Abdominal Liver Mass.
    Gastroenterology. 2018;155:e12-e13.

  192. WENDT S, Lubbert C, Karlas T
    An Emerging Cause for Liver Abscesses With Poor Prognosis.
    Gastroenterology. 2018;155:e18-e19.

  193. JIANG ZG, Vardeh H, Evenson A
    A Case of Cryptogenic Liver Failure.
    Gastroenterology. 2018;155:23-24.

  194. SAFFIOTI F, Mookerjee RP
    When Going With the Flow Sends You Upstream.
    Gastroenterology. 2018;155:21-22.

    June 2018
  195. PRADHAN-SUNDD T, Vats R, Russell JM, Singh S, et al
    Dysregulated bile transporters and impaired tight junctions during chronic liver injury in mice.
    Gastroenterology. 2018 Jun 28. pii: S0016-5085(18)34690.
    PubMed     Abstract available

  196. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Abstract available

  197. MUSSO G, Cassader M, Paschetta E, Gambino R, et al
    Bioactive lipid species and metabolic pathways in progression and resolution of Non-Alcoholic Steatohepatitis.
    Gastroenterology. 2018 Jun 12. pii: S0016-5085(18)34642.
    PubMed     Abstract available

  198. SHAH SM, Kamboj AK, Cleary SP
    Large Hepatic Mass in an Adolescent Male.
    Gastroenterology. 2018 Jun 5. pii: S0016-5085(18)34607.

    May 2018
  199. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.

  200. LIU T, Yang H, Fan W, Tu J, et al
    Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Gastroenterology. 2018 May 4. pii: S0016-5085(18)34482.
    PubMed     Abstract available

  201. COSTENTIN C, Layese R, Bourcier V, Cagnot C, et al
    Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-time Adjusted Survival of Patients With Compensated Viral Cirrhosis.
    Gastroenterology. 2018 May 2. pii: S0016-5085(18)30488.
    PubMed     Abstract available

  202. CHUNG HH
    The Multiple Modulation of miR-122 in the Attenuation of Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1857.

  203. GUILLAUME M, Bureau C
    Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome?
    Gastroenterology. 2018;154:1569-1571.

  204. WU J, Yang S, Xu K, Ding C, et al
    Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030.
    Gastroenterology. 2018;154:1719-1728.
    PubMed     Abstract available

  205. IBRAHIM M, Mostafa I, Deviere J
    New Developments in Managing Variceal Bleeding.
    Gastroenterology. 2018;154:1964-1969.
    PubMed     Abstract available

  206. CHEN YY, Chen CC
    Progression of an Unusual Primary Liver Tumor.
    Gastroenterology. 2018;154:1590-1591.

    April 2018
  207. CAO P, Yang A, Wang R, Xia X, et al
    Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30481.
    PubMed     Abstract available

  208. EZCURRA I, Fortea JI, Crespo J
    A rare but recognizable cholestatic liver disease.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30484.

  209. CALVARUSO V, Cabibbo G, Cacciola I, Petta S, et al
    Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441.
    PubMed     Abstract available

  210. LEE BP, Mehta N, Platt L, Gurakar A, et al
    Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30442.
    PubMed     Abstract available

  211. FIRL DJ, Sasaki K, Aucejo FN
    Prognosticating the Candidate Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30306.

  212. SCOTT RA, Aithal GP, Francis ST, Irving WL, et al
    Pretreatment Lesions on Magnetic Resonance Imaging in Patients With Hepatitis C Virus Infection Diagnosed With Hepatocellular Carcinoma After Initiating Direct-Acting Antiviral Therapy.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30305.

    Nonalcoholic Fatty Liver Disease in Alcohol Users: An Oxymoron?
    Gastroenterology. 2018;154:1549-1550.

  214. GHOSH G, Shen NT, Jesudian AB
    Coffee Bean Sign With a Twist.
    Gastroenterology. 2018;154:e10-e11.

  215. THIELE M, Madsen BS, Hansen JF, Detlefsen S, et al
    Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1369-1379.
    PubMed     Abstract available

    March 2018
  216. BAI J, Zheng L, Han Y
    Unexpected findings in a patient with hepatomegaly and skin rashes.
    Gastroenterology. 2018 Mar 13. pii: S0016-5085(18)30318.

  217. GRUNVOGEL O, Colasanti O, Lee JY, Kloss V, et al
    Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll Like Receptor 3 in Hepatocytes.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30309.
    PubMed     Abstract available

  218. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    PubMed     Abstract available

  219. CHUNG HH
    New Insights for Controversial Issues of miR-122 in Hepatic Lipid Metabolism.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30146.

  220. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.

  221. BER TI, Ilan Y
    Biomarkers for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30151.

  222. MANDORFER M, Reiberger T, Peck-Radosavljevic M
    Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30150.

  223. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.

  224. HARVEY LD, Chan SY
    YAPping About Glutaminolysis in Hepatic Fibrosis.
    Gastroenterology. 2018 Mar 3. pii: S0016-5085(18)30259.

  225. MCGEOCH LJ, Patel PR, Mann JP
    PNPLA3: A Determinant of Response to Low-Fructose Diet in Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;154:1207-1208.

  226. LI G, Liu D, Kimchi ET, Kaifi JT, et al
    Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Gastroenterology. 2018;154:1024-1036.
    PubMed     Abstract available

  227. ANDERSSON ER, Chivukula IV, Hankeova S, Sjoqvist M, et al
    Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.
    Gastroenterology. 2018;154:1080-1095.
    PubMed     Abstract available

  228. HOFLAND J, Koch AD, de Herder WW
    Melena in a Patient With a Metastasized Neuroendocrine Tumor.
    Gastroenterology. 2018;154:e6-e7.

    February 2018
  229. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Abstract available

  230. DOU C, Liu Z, Tu K, Zhang H, et al
    P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-promoting Myofibroblasts.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30209.
    PubMed     Abstract available

  231. CHEN C, Soto-Gutierrez A, Baptista PM, Spee B, et al
    Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.
    Gastroenterology. 2018 Feb 8. pii: S0016-5085(18)30166.
    PubMed     Abstract available

  232. TZARTZEVA K, Obi J, Rich NE, Parikh ND, et al
    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30155.
    PubMed     Abstract available

  233. LIVERANI E, Colecchia A, Mazzella G
    Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome.
    Gastroenterology. 2018;154:495-497.

    January 2018
  234. YOSHIKAWA T, Ohana M, Fukuda A
    High fever after radiofrequency ablation of hepatocellular carcinoma.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30134.

  235. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    PubMed     Abstract available

  236. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.

  237. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.

  238. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.

  239. HORVAT N, Ragucci M, Mannelli L
    Hepatic Mass in a Patient With Bladder Cancer History.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)35643.

  240. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.

  241. DU K, Hyun J, Premont RT, Choi SS, et al
    Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Hepatic Stellate Cell Activation.
    Gastroenterology. 2018 Jan 3. pii: S0016-5085(18)30002.
    PubMed     Abstract available

  242. MAURICE JB, Yu D, Watkins J
    A 41-Year-Old Man With Abdominal Pain, Deranged Liver Function, and Fevers.
    Gastroenterology. 2018;154:26-27.

  243. LEE CW, Chen YF, Wu HH, Lee OK, et al
    Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.
    Gastroenterology. 2018;154:46-56.
    PubMed     Abstract available

  244. SATISHCHANDRAN A, Ambade A, Rao S, Hsueh YC, et al
    MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Gastroenterology. 2018;154:238-252.
    PubMed     Abstract available

  245. PIERSON H, Muchenditsi A, Kim BE, Ralle M, et al
    The Function of ATPase Copper Transporter ATP7B in Intestine.
    Gastroenterology. 2018;154:168-180.
    PubMed     Abstract available

    December 2017
  246. WU X, Dao Thi VL, Liu P, Takacs CN, et al
    Pan-Genotype Hepatitis E Virus Replication in Stem Cell-derived Hepatocellular Systems.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36303.
    PubMed     Abstract available

  247. POURCET B, Zecchin M, Ferri L, Beauchamp J, et al
    Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity Of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36725.
    PubMed     Abstract available

  248. ZHANG S, Nguyen LH, Zhou K, Tu HC, et al
    Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice without Affecting Regeneration.
    Gastroenterology. 2017 Dec 20. pii: S0016-5085(17)36717.
    PubMed     Abstract available

    November 2017
    The Role of Transforming Growth Factor-beta in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications from an Integrative Multiomics Approach.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36373.

  250. BI D, Malikowski TM, Sweetser S
    Portal Hypertension and Unexplained Diarrhea in an 80-year-old man.
    Gastroenterology. 2017 Nov 6. pii: S0016-5085(17)36339.

  251. KAKAR S, Borhani AA, Malik SM
    A Liver Full of Stars: Hepatostellular!
    Gastroenterology. 2017 Nov 4. pii: S0016-5085(17)35453.

  252. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    PubMed     Abstract available

  253. VANWAGNER LB, Ning H, Allen NB, Ajmera V, et al
    Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;153:1260-1272.
    PubMed     Abstract available

  254. D'MELLO C, Almishri W, Liu H, Swain MG, et al
    Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.
    Gastroenterology. 2017;153:1416-1428.
    PubMed     Abstract available

  255. MOON H, Ju HL, Chung SI, Cho KJ, et al
    Transforming Growth Factor-beta Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Gastroenterology. 2017;153:1378-1391.
    PubMed     Abstract available

    October 2017
  256. MAZZAFERRO V, Sposito C, Zhou J, Pinna AD, et al
    Metroticket 2.0 Model for Analysis of Competing Risks of Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36184.
    PubMed     Abstract available

  257. CAO W, Chen K, Bolkestein M, Yin Y, et al
    Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury.
    Gastroenterology. 2017;153:1133-1147.
    PubMed     Abstract available

  258. HSU EK, Shaffer ML, Gao L, Sonnenday C, et al
    Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Gastroenterology. 2017;153:988-995.
    PubMed     Abstract available

  259. CHEN ZH, Yu YP, Tao J, Liu S, et al
    MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.
    Gastroenterology. 2017;153:1120-1132.
    PubMed     Abstract available

    September 2017
  260. ZHANG K, Kim H, Fu Z, Qiu Y, et al
    Deficiency of the Mitochondrial NAD Kinase Causes Stress-induced hepatic steatosis in mice.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36150.
    PubMed     Abstract available

  261. ENGELHOLM LH, Riaz A, Serra D, Dagnaes-Hansen F, et al
    CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Gastroenterology. 2017 Sep 15. pii: S0016-5085(17)36148.
    PubMed     Abstract available

  262. CHEN J, Zaidi S, Rao S, Chen JS, et al
    Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor beta Pathway Short title: Prognostic significance of TGF-beta signature in liver cancer.
    Gastroenterology. 2017 Sep 14. pii: S0016-5085(17)36144.
    PubMed     Abstract available

  263. KESAR V, Swaminath A
    Hepatic masses in a patient in Inflammatory bowel disease.
    Gastroenterology. 2017 Sep 9. pii: S0016-5085(17)36140.

  264. ESO Y, Mishima M, Fukuda A
    An Unusual Cause of Hepatic Dysfunction.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35460.

    August 2017
  265. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.

  266. CRISMALE JF, Ward SC, Ahmad J
    An Unusual Cause of Abdominal Pain and Biliary Obstruction in a Patient with Hepatocellular Carcinoma.
    Gastroenterology. 2017 Aug 30. pii: S0016-5085(17)36074.

  267. KIM K, Ryu D, Dongiovanni P, Ozcan L, et al
    Degradation of PHLPP2 by KCTD17, via a Glucagon-dependent Pathway, Promotes Hepatic Steatosis.
    Gastroenterology. 2017 Aug 28. pii: S0016-5085(17)36072.
    PubMed     Abstract available

  268. SCHMIDT-MARTIN D, Armstrong MJ, Rowe IA
    Transplant-Free Survival Rates After Covered Transjugular Intrahepatic Portosystemic Shunt.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35885.

  269. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Abstract available

    July 2017
  270. PATEL YA, Imperial J, Muir AJ, Anstee QM, et al
    Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations from the Liver Forum.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35955.
    PubMed     Abstract available

  271. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Abstract available

  272. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    PubMed     Abstract available

  273. KING A, Houlihan DD, Kavanagh D, Haldar D, et al
    Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology. 2017;153:233-248.
    PubMed     Abstract available

  274. KHAMRI W, Abeles RD, Hou TZ, Anderson AE, et al
    Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Gastroenterology. 2017;153:263-276.
    PubMed     Abstract available

    June 2017
  275. ZHOU G, Sprengers D, Boor PPC, Doukas M, et al
    Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-infiltrating T cells in Hepatocellular Carcinomas.
    Gastroenterology. 2017 Jun 22. pii: S0016-5085(17)35802.
    PubMed     Abstract available

  276. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Abstract available

  277. VANCLOOSTER A, van Deursen C, Jaspers R, Cassiman D, et al
    Proton pump inhibitors decrease phlebotomy need in HFE hemochromatosis: double-blind randomized placebo-controlled trial.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35740.

  278. NANO J, Ghanbari M, Wang W, de Vries PS, et al
    Epigenome-wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35737.
    PubMed     Abstract available

  279. SIA D, Jiao Y, Martinez-Quetglas I, Kuchuk O, et al
    Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35741.
    PubMed     Abstract available

  280. MIDDLETON MS, Heba ER, Hooker CA, Bashir MR, et al
    Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-assigned Steatosis Grades of Liver Biopsies from Adults with Nonalcoholic Steatohepatitis.
    Gastroenterology. 2017 Jun 14. pii: S0016-5085(17)35739.
    PubMed     Abstract available

  281. JIN B, Du G, Li T
    Right Upper Abdominal Distension and Discomfort Caused by a Massive Hepatic Tumor.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(16)35356.

  282. JIN H, Wang C, Jin G, Ruan H, et al
    Regulator of Calcineurin 1 Gene Isoform 4, Downregulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Growth of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35687.
    PubMed     Abstract available

  283. CANNON MD, Heneghan MA
    Endoscopy in Pregnant Women with Liver Cirrhosis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35602.

  284. WEILER SME, Pinna F, Wolf T, Lutz T, et al
    Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Gastroenterology. 2017;152:2037-2051.
    PubMed     Abstract available

  285. XIMENES RO, Vieira Costa JP, Pereira E Silva KT
    Cullen's sign - not always acute pancreatitis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35650.

    May 2017
  286. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Abstract available

  287. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.

  288. TAN HK, Leow WQ, Chang PE
    Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(16)35073.

  289. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.

  290. ROCCARO GA, Goldberg DS
    Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?
    Gastroenterology. 2017 May 3. pii: S0016-5085(17)35551.

  291. ABATE N, Chandalia M
    Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians.
    Gastroenterology. 2017;152:1647-1655.
    PubMed     Abstract available

  292. CAMILLERI M, Malhi H, Acosta A
    Gastrointestinal Complications of Obesity.
    Gastroenterology. 2017;152:1656-1670.
    PubMed     Abstract available

  293. LAI KKY, Kweon SM, Chi F, Hwang E, et al
    Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Gastroenterology. 2017;152:1477-1491.
    PubMed     Abstract available

    April 2017
  294. KALYAN A, Kulik L
    Multi-disciplinary Care in Hepatocellular Carcinoma: Where Do We Go from Here?
    Gastroenterology. 2017 Apr 28. pii: S0016-5085(17)35538.

  295. CUI L, Nakano K, Obchoei S, Setoguchi K, et al
    Small Nucleolar Noncoding RNA SNORA23, Upregulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of SYNE2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35402.
    PubMed     Abstract available

  296. PAN LH, Zhao C, Ma YL
    Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?
    Gastroenterology. 2017 Apr 3. pii: S0016-5085(17)30221.

  297. DURAN R, Deltenre P, Denys A
    RE: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30224.

  298. NICOLETTI P, Aithal GP, Bjornsson ES, Andrade RJ, et al
    Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Gastroenterology. 2017;152:1078-1089.
    PubMed     Abstract available

  299. AN SY, Jang YJ, Lim HJ, Han J, et al
    Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    Gastroenterology. 2017;152:1174-1186.
    PubMed     Abstract available

  300. SONG CQ, Li Y, Mou H, Moore J, et al
    Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.
    Gastroenterology. 2017;152:1161-1173.
    PubMed     Abstract available

    March 2017
  301. YOUNG S, Golzarian J
    Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30225.

  302. GARIN E, Pallard X, Edeline J
    Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
    Gastroenterology. 2017 Mar 31. pii: S0016-5085(17)30222.

  303. ZHANG W, He H, Zang M, Wu Q, et al
    Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30333.
    PubMed     Abstract available

  304. HOWELL J, Thompson AJ
    Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Gastroenterology. 2017 Mar 28. pii: S0016-5085(17)30334.

  305. ALVARO D
    Gallstones: bad company for the steatotic liver.
    Gastroenterology. 2017 Mar 25. pii: S0016-5085(17)30329.

  306. DURNO C, Boland CR, Cohen S, Dominitz JA, et al
    Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2017 Mar 22. pii: S0016-5085(17)30175.
    PubMed     Abstract available

  307. SIA D, Villanueva A, Friedman SL, Llovet JM, et al
    Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Gastroenterology. 2017;152:745-761.
    PubMed     Abstract available

  308. HENDIFAR AE, Davies L, Tuli R
    Private Funding for Pancreatic Cancer Research: More Than a Chip Shot.
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30229.

    February 2017
  309. CHAVEZ-TALAVERA O, Tailleux A, Lefebvre P, Staels B, et al
    Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD.
    Gastroenterology. 2017 Feb 15. pii: S0016-5085(17)30157.
    PubMed     Abstract available

  310. PATEL SH, Camargo FD, Yimlamai D
    Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
    Gastroenterology. 2017;152:533-545.
    PubMed     Abstract available

  311. PARK CC, Nguyen P, Hernandez C, Bettencourt R, et al
    Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;152:598-607.
    PubMed     Abstract available

  312. MARKOVA M, Pivovarova O, Hornemann S, Sucher S, et al
    Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Gastroenterology. 2017;152:571-585.
    PubMed     Abstract available

    January 2017
  313. ASAI Y, Yamada T, Tsukita S, Takahashi K, et al
    Activation of the Hypoxia Inducible Factor 1 Alpha Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30012.
    PubMed     Abstract available

  314. WOODEN B, Goossens N, Hoshida Y, Friedman SL, et al
    Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.
    Gastroenterology. 2017;152:53-67.
    PubMed     Abstract available

    December 2016
  315. RICH N, Singal AG
    Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Potential New Challenge for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2016;151:1246-1248.

    October 2016
  316. ZHANG YM, Wang J, Chen DF
    A Rare Cause of Massive Upper Gastrointestinal Bleeding.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)34648.

    TIMPing Fate: Why Pancreatic Cancer Cells Sojourn in the Liver.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35132.

    May 2016
  318. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Abstract available

    Entering the GOLDEN Age for Therapies in NASH.
    Gastroenterology. 2016;150:1073-6.

    February 2016
  320. WANG L, Yin J, Wang X, Shao M, et al
    C-type Lectin-like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of PI3K Subunits.
    Gastroenterology. 2016 Feb 5. pii: S0016-5085(16)00133.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.